Abstract. Reports have suggested that spindle cell carcinoma of the head and neck occurs following radiation therapy of incompletely resected SCC, representing anaplastic progression of the primary tumor. Examination of differences between spindle cell carcinoma and SCC may provide important information about anaplastic progression, clinical behavior, and response to therapy. We created a mouse model that developed spindle cell carcinoma. Spindle cell carcinoma was characterized by marked downregulation of epithelial differentiation markers and cell adhesion genes. Expression of growth factors and receptors important for epithelial proliferation was inhibited while those which regulate fibroblast and mesenchymal cell proliferation were increased. By far the largest class of upregulated genes in spindle cell carcinomas was chemokine receptors and ligands which are involved in tumor cell invasion and metastasis. These changes in gene expression clearly show loss of epithelial characteristics, acquisition of mesenchymal phenotypes, and increased propensity for invasion and metastasis by spindle cell carcinomas.
Introduction
Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most frequent cancer worldwide (1) . HNSCC is a major cause of morbidity and mortality in developing nations, comprising up to 50% of all malignancies. HNSCC is the most common malignant tumor of the oral cavity with nearly 30,000 new cases and 8,000 deaths reported in the United States each year (2) . Tobacco carcinogens are the primary etiologic agents of the disease with age and genetic background as contributory factors. The overall 5-year survival rate of approximately 50% has not changed significantly in recent decades.
A recent report identified a shortage of suitable animal models with which to study different biological and clinical aspects of HNSCC (3) . Because HNSCC is largely acquired by environmental carcinogen exposure rather than through germline mutations, there are no known familial forms of the disease in humans nor are there inbred rodent strains prone to spontaneous head and neck tumors (4) . A classical animal model of HNSCC was carcinogen exposure of the hamster buccal cheek pouch (5) . A second model of HNSCC relied on human tumor cell xenografts in immunodeficient mice. Studies using this model subcutaneously injected cultured human HNSCC cells into the backs of nude mice (6) . These models have been used in many types of cancer to determine in vivo tumorigenicity but typically fail to replicate local invasion and lymph node metastasis of HNSCC. Variations on this model have injected human tumor cells into other anatomic sites (7, 8) . However, the xenograft models are limited to human cancer cell lines that can adapt to the murine environment and do not replicate the early stages of carcinogenesis. A transgenic mouse model expressing activated K-ras reportedly developed epithelial lesions ranging from oral papillomas (9) to squamous cell carcinomas of skin, esophagus, stomach, uterine cervix, oral mucosa, and salivary glands (10) . However, K-ras is reported to be infrequently mutated in human HNSCC cases (11, 12) .
Spindle cell carcinoma of the head and neck is believed to be a rare variant of squamous cell carcinoma. Previous reports have suggested that spindle cell carcinoma occurs following radiation therapy of incompletely resected SCC, representing anaplastic progression of the primary tumor (13) . Spindle cell carcinoma was present in 40% of recurrent tumors following treatment when it was not noted in the original tumor (14) . Spindle cell carcinoma is believed to be a distinct histopathologic entity with both monophasic and biphasic patterns. Biphasic spindle cell carcinomas have been shown to express keratin in the spindle cell component (15) . These tumors also expressed the fibroblast marker vimentin but were S100 negative (16) . Previous studies have suggested that these tumors are aggressive, with 2-year survival rates of 30% (17) . Prognostic factors included patient age and size of the primary tumor but not the degree of cervical lymph node involvement. Clinical responses to chemotherapy regimens were reported to be 50% (18) .
Little is known about the genetic differences between SCC and spindle cell carcinoma. Examination of these differences may provide important information about anaplastic progression, clinical behavior, and response to chemotherapy. Due to the small number of available human cases of spindle cell carcinoma, we created a mouse model that developed spindle cell carcinoma in 10% of experimental animals. When the expression of gene products commonly altered in human SCC was assessed, spindle cell carcinomas showed dramatic differences when compared to mouse and human SCC. Using global gene expression profiling, spindle cell carcinomas notably demonstrated loss of stratified epithelial gene expression and upregulation of chemokine receptors and ligands. These studies highlight for the first time important differences between SCC and spindle cell carcinoma that may be important to human cancer.
Materials and methods
Mouse procedures. This study was approved by the Institutional Animal Care and Use Committee before any experiments were performed. C57Bl6J mice were housed in approved environmentally controlled facilities on 12-h light-dark cycles and unlimited access to food and water. Twenty-eight male and female mice were dosed orally twice weekly with 25 μg dimethylbenzanthracene (DMBA) dissolved in 20 μl ethanol. The time course and number of tumors were recorded for each animal. Mice were euthanized when any institutional criterion for experimental neoplasia in rodents was met. Euthanized mice were photographed and complete necropsies performed. A portion of each tumor specimen was flash frozen in liquid nitrogen or fixed in 4% buffered formaldehyde for 16 h at room temperature.
Histopathology and immunohistochemistry. Tumor tissue was dehydrated in an ethanol series, cleared in xylene, and embedded in paraffin. Five μm sections were prepared and mounted on poly-L-lysine coated slides. Representative sections were stained with hematoxylin and eosin and histologically evaluated by a pathologist. Immunohistochemical analysis was performed using a commercially available kit (Invitrogen, Carlsbad, CA). Sections were incubated at 60˚C for 30 min and deparaffinized in xylene. Endogenous peroxidase activity was quenched by incubation in 9:1 methanol: 30% hydrogen peroxide for 10 min at room temperature. Sections were rehydrated in phosphate-buffered saline (PBS, pH 7.4) for 10 min at room temperature. Sections were blocked with 10% normal serum for 10 min at room temperature followed by incubation with anti-p53, met, c-myc, TERT, EGFR, cyclin A, cyclin B, cyclin E, TGF·, HGF, and PCNA antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) for 16 h at room temperature. After washing three times in PBS, the sections were incubated with secondary antibody conjugated to biotin for 10 min at room temperature. After additional washing in PBS, the sections were incubated with streptavidin conjugated horseradish peroxidase enzyme for 10 min at room temperature. Following final washes in PBS, antigenantibody complexes were detected by incubation with hydrogen peroxide substrate solution containing aminoethylcarbazole chromogen reagent. Slides were rinsed in distilled water, coverslipped using aqueous mounting medium, and allowed to dry at room temperature. The relative intensities of the completed immunohistochemical reactions were evaluated using light microscopy by independent trained observers who were unaware of the mouse genotypes. A scale of 0-3 was used to score relative intensity, with 0 corresponding to no detectable immunoreactivity and 1, 2, and 3 equivalent to low, moderate, and high staining respectively. Non-parametric data was analyzed by Fisher's exact test.
RNA extraction and gene expression profiling. Total RNA was extracted from microdissected primary tumor tissue using a commercially available kit (RNasy, Qiagen, Valencia, CA). Three independent samples from each group (well-, moderate-, and poorly-differentiated/spindle cell) were used in this gene expression analysis. The integrity of ribosomal RNA bands was confirmed by Northern gel electrophoresis. Total RNA (10 μg) with spike in controls was first reverse-transcribed using a T7-oligo(dT) promoter primer in the first-strand cDNA synthesis reaction. Following RNase H-mediated secondstrand cDNA synthesis, the double-stranded cDNA was purified and served as a template in the subsequent in vitro transcription (IVT) reaction. The IVT reaction was carried out in the presence of T7 RNA polymerase and a biotinylated nucleotide analog/ribonucleotide mix for complementary RNA (cRNA) amplification and biotin labeling. The biotinylated cRNA targets were then purified, fragmented, and hybridized to Affymetrix GeneChip expression arrays (Santa Clara, CA). The murine genome 430 2.0 microarray was used to interrogate 39,000 possible transcripts in each sample. After washing, hybridization signals were detected using streptavidin conjugated phycoerythrin. Affymetrix GCOS software was used to generate raw gene expression scores and normalized to the relative hybridization signal from each experiment. All gene expression scores were set to a minimum value of 2 times the background determined by GCOS software in order to minimize noise associated with less robust measurements of rare transcripts. Normalized gene expression data were imported into dChip software (http://www.biostat.harvard. edu/complab/dchip) for hierarchical clustering analysis using the average linkage algorithm. Raw data were analyzed for quality control and the significance of differential gene expression determined by t-test (p<0.05) and ratio analysis (>2-fold).
Results
All mice (n=28) treated with twice weekly doses of DMBA developed papillomas after mean 22 weeks induction on the labial and buccal mucosa which grew larger and progressed to large tumors in the absence of additional induction. Mice developed euthanasia criteria with mean time course of 13 weeks after onset of tumors. The most common criterion was weight loss followed by tumor size. The gross appearance of well-differentiated SCC, moderately-differentiated SCC, and spindle cell carcinoma arising from the labial mucosa in the mouse model is shown in Fig. 1 .
Histopathologic analysis of primary tumors from this model is shown in Fig. 2 . At necropsy, the advanced stage HNSCCs showed clear evidence of tumor progression with all degrees of differentiation represented. Well-differentiated SCC was the predominant histologic type in 18 of 28 tumors examined by histopathology (64%; Fig. 2A ). These tumors demonstrated extensive basal layer and suprabasal differentiation with evidence of basement membrane formation and prominent keratinization. Seven tumors were histopathologically classified as moderately-differentiated (25%; Fig. 2B ). These tumors showed less evidence of stratification, basement membrane production, and keratin formation. These carcinomas were also characterized by loss of intercellular junctions, increased nuclear/cytoplasmic ratio, nuclear pleiomorphism, and occasional mitotic figures. Three tumors were classified as poorly-differentiated or anaplastic (11%; Fig. 2C ). These tumors were composed of sheets and bundles of spindle shaped cells with elongated nuclei and complete loss of intercellular junctions. Eosinophilic inclusions were frequently observed in the cytoplasm of these cells which likely represented abnormal keratin production; mitotic figures were rarely observed in these tumors. These results indicate that the mouse HNSCC model can recapitulate the full histopathologic spectrum of tumors found in the human disease.
Our previous studies of human SCC showed that cyclin overexpression was a common feature of these tumors (19) . To determine if these alterations in gene expression were observed in spindle cell carcinoma, we performed immunohistochemistry on these cancers and compared the results to those obtained in mouse SCC. As shown in cyclin E protein compared to none of the spindle cell carcinomas (p<0.01). These results indicate that loss of cell cycle regulatory protein expression is a consistent feature of spindle cell carcinoma.
Our previously published results showed that growth factors and their receptors were frequently overexpressed in human SCC (19) . To determine if these proteins were overexpressed in mouse SCC and spindle cell carcinoma we examined EGFR, TGF·, met, and HGF by immunohistochemistry. As shown in Fig. 4 , mouse SCC overexpressed both growth factor receptors and their ligands. Approximately 40% of SCCs overexpressed EGFR compared to none of the spindle cell carcinomas (p<0.01). Approximately 50% of SCCs overexpressed met while this protein was not detected in any of the spindle cell carcinomas (p<0.02). TGF· and HGF proteins were overexpressed in 80% of SCCs but not in any cases of spindle cell carcinoma (p<0.01). These results indicate that loss of growth factor receptors and their ligands is a common feature of spindle cell carcinomas.
We also examined expression of p53, c-myc, TERT, and PCNA in mouse SCCs and spindle cell carcinomas. While p53 protein was detected in 90% of SCCs, we did not detect its expression in spindle cell carcinomas (p<0.001; Fig. 5 ). c-myc protein was detected in approximately 30% of SCCs but none of the spindle cell carcinomas (p<0.05). TERT was detected to variable extent in all SCCs but not in spindle cell carcinomas (p<0.001). PCNA expression was detected to variable extent in all SCCs but not in spindle cell carcinomas (p<0.001). Taken together, these results indicate that spindle cell carcinomas do not overexpress growth factor receptors, ligands, cell cycle regulatory proteins, and tumor suppressors normally found in human and mouse SCCs.
Our immunohistochemical data indicated that spindle cell carcinomas were substantially different with regard to genes commonly overexpressed in SCCs. To better understand the genetic differences between SCCs and spindle cell carcinomas, we used microarray analysis to globally profile gene expression. As shown in Fig. 6A , 91 genes were upregulated and 73 genes were downregulated when well-differentiated and moderatelydifferentiated SCCs were compared. In contrast, 919 genes were upregulated and 202 genes were downregulated when well-differentiated SCC was compared to spindle cell carcinoma. Similarly, 870 genes were upregulated and 423 genes were downregulated when moderately-differentiated SCC was compared to spindle cell carcinoma. Dendrogram analysis revealed that well and moderately-differentiated SCCs were highly related to each other by gene expression profile while spindle cell carcinoma was distantly related to SCCs (Fig. 6B) . Gene expression changes between well-and moderately-differentiated SCC are shown in Table I . Gene expression changes between these two cancers and spindle cell carcinoma are shown in Tables II and III . Spindle cell carcinoma was characterized by marked downregulation of stratified squamous epithelial terminal differentiation markers such as the group of small proline rich proteins, loricrin, transglutaminase, and involucrin. Expression of a large number of keratin genes which are markers of epithelial differentiation was also dramatically inhibited in spindle cell carcinoma. Levels of cellular adhesion genes were substantially downregulated in spindle cell carcinoma including desmogleins 1· and ß, cadherin 1, plakophilin 3, desmocollins 2 and 3, and desmoplakin. Expression of growth factors and receptors important for epithelial proliferation was inhibited, namely transforming growth factor ·, amphiregulin, and the EGFR family member Erbb3. By contrast, expression of growth factors and receptors important in fibroblast and mesenchymal cell proliferation was enhanced including transforming growth factor ß receptors type II and III, bone morphogenetic protein 4, and insulin like growth factor 1. Expression of a number of proteinase inhibitors was downregulated (serpins A3, B3A, B3B, B5, B6C, B12) while protease expression (matrix metalloproteinase 2, serine protease 35) was increased in spindle cell carcinomas. By far the largest class of upregulated genes in spindle cell carcinomas was chemokine receptors and ligands which are involved in tumor cell invasion and metastasis. These changes in gene expression clearly show loss of epithelial characteristics, acquisition of mesenchymal phenotypes, and increased propensity for invasion and metastasis by spindle cell carcinomas.
Discussion
Little is known about the genetic differences between SCC and spindle cell carcinoma. Examination of these differences may provide important information about anaplastic progression, clinical behavior, and response to chemotherapy. We created a mouse model in which spindle cell carcinoma occurs in 10% of animals. These tumors were composed of sheets and bundles of spindle shaped cells with elongated nuclei and loss of intercellular junctions. Eosinophilic inclusions were frequently observed in the cytoplasm of these cells which likely represented abnormal keratin production; mitotic figures were rarely observed in these tumors. Consistent with this histopathology, spindle cell carcinoma was characterized by marked downregulation of stratified squamous epithelial terminal differentiation markers such as the group of small proline rich proteins, loricrin, transglutaminase, and involucrin. Expression of a large number of keratin genes which are markers of epithelial differentiation was also dramatically inhibited in spindle cell carcinoma. Levels of cell adhesion genes were substantially downregulated in spindle cell carcinoma including desmogleins 1· and ß, cadherin 1, plakophilin 3, desmocollins 2 and 3, and desmoplakin. These results indicate substantial loss of epithelial characteristics in spindle cell carcinomas.
Further evidence of major differences between SCC and spindle cell carcinoma was observed when examining expression of gene products normally overexpressed in human SCC. SCCs overexpressed cyclins A, B, and E as shown by immunohistochemistry. However, spindle cell carcinomas did not overexpress any of these cyclins. Similarly SCCs overexpressed EGFR and met and their ligands TGF· and HGF compared to none of the spindle cell carcinomas. Downregulation of these and other epithelial growth factors and receptors also were noted in gene expression profiling studies of spindle cell carcinomas. By contrast, expression of growth factors and receptors important in fibroblast and mesenchymal cell proliferation was enhanced including transforming growth factor ß receptors type II and III, bone morphogenetic protein 4, and insulin like growth factor 1. These results indicate that proliferation of SCCs and spindle cell carcinomas is regulated by markedly different sets of growth factors.
Spindle cell carcinomas were characterized by striking upregulation of chemokine ligands and receptors. Chemokine receptors are involved in breast cancer metastasis, in particular CXCR4, CXCR2, CCR7, and CCR8 (20) . In future experiments, it will be important to determine the role of chemokine receptors in spindle cell carcinoma progression, proliferation, and metastasis. Expression of a number of proteinase inhibitors was downregulated while protease expression was increased in spindle cell carcinomas. Additionally, expression of transmembrane gene products semaphorins and mesothelin was upregulated in spindle cell carcinomas. Both of these proteins have been implicated in tumor progression and metastasis (21, 22) . Both in vitro and in vivo experiments will be required to determine if spindle cell carcinomas are more invasive and metastatic compared to SCC.
While spindle cell carcinoma has been recognized as a distinct histopathologic entity, the role of epithelialmesenchymal transition in neoplasia has been debated recently Table I . Gene expression changes between well-and moderately-differentiated SCC. ---------------------------------------------------------------------------------------------------- -Table II . Gene expression changes between well-differentiated SCC and spindle cell carcinoma. ---------------------------------------------------------------------------------------------------- -Table III . Gene expression changes between moderately-differentiated SCC and spindle cell carcinoma. -----------------------------------------------------------------------------------------------------(23,24) . Until now, global gene expression profiling of spindle cell carcinoma has not been undertaken. Our results show distinct gene expression profiles between SCC and spindle cell carcinoma. Future studies using this model system will contribute to the debate over epithelial-mesenchymal transition and help us to understand the genetic basis of tumor progression, proliferation, invasion, and metastasis in SCC and spindle cell carcinoma.
-----------------------------------------------------------------------------------------------------Accession Symbol Gene name Fold change -----------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------- Accession Symbol Gene name Fold change ----------------------------------------------------------------------------------------------------- NM_033175 Sprrl1----------------------------------------------------------------------------------------------------- Accession Symbol Gene name Fold change ----------------------------------------------------------------------------------------------------- NM_008475 Krt2-4
